fda approves first oral glp-1 obesity drug august 21 2025 The approved a new pill from Eli Lilly on Wednesday. The drug, called Foundayo, is the second GLP-1 weight-loss pill. CBS News' Dr. LaPook has more on the new medication FDA Approves First Oral GLP-1
Description
Ryan et al
95% CI, 0.401.14) but not stroke (adjusted pooled HR, 1.05
CD36 and ACAT-1 are connected with macrophage foam cell formation and aortic smooth muscle cell proliferation
Zepbound is unique because it acts on two gut hormones (GLP-1 and GIP), offering additional benefits
